Tenet Health(US:THC) ZACKSยท2024-06-24 23:21Company Overview - Tenet Healthcare's stock has increased by 2.38% over the past month, outperforming the Medical sector's gain of 0.61% but underperforming the S&P 500's gain of 2.73% [1] - The stock closed at $136.03, showing a +1.33% change from the previous day's closing price, while the S&P 500 declined by 0.31% on the same day [5] Financial Performance - For the full year, Zacks Consensus Estimates project earnings of $8.74 per share and revenue of $20.34 billion, reflecting changes of +25.21% and -1.04% respectively from the previous year [6] - The upcoming earnings release is scheduled for July 24, 2024, with an anticipated EPS of $1.83, indicating a 27.08% increase compared to the same quarter last year, while revenue is expected to be $4.98 billion, down 2.03% from the prior year quarter [9] Valuation Metrics - Tenet Healthcare is currently trading at a Forward P/E ratio of 15.35, which is lower than the industry average Forward P/E of 15.78, indicating a discount relative to its peers [3] - The company has a PEG ratio of 1.36, compared to the industry average PEG ratio of 1.47, suggesting a favorable valuation in terms of growth expectations [11] Analyst Sentiment - Recent revisions to analyst forecasts for Tenet Healthcare indicate a favorable outlook on the company's business health and profitability, with the consensus EPS projection having increased by 0.14% in the past 30 days [2][10] - Tenet Healthcare holds a Zacks Rank of 1 (Strong Buy), which has historically outperformed with an average annual return of +25% since 1988 [7] Industry Context - The Medical - Hospital industry, which includes Tenet Healthcare, has a Zacks Industry Rank of 30, placing it in the top 12% of over 250 industries [8]